Arbor Realty Trust Schedules Third Quarter 2016 Earnings Conference Call
Oct 28, 2016 12:00 pm UTC| Business
UNIONDALE, N.Y., Oct. 28, 2016 -- Arbor Realty Trust, Inc. (NYSE:ABR), today announced that it is scheduled to release third quarter 2016 financial results before market open on Friday, November 4, 2016. The Company...
Oct 28, 2016 12:00 pm UTC| Business
ISELIN, N.J., Oct. 28, 2016 -- Provident Financial Services, Inc. (NYSE:PFS) (the “Company”) reported net income of $22.9 million, or $0.36 per basic and diluted share, for the three months ended September 30, 2016,...
Aclaris Therapeutics Honored as One of the Best Places to Work in Pennsylvania
Oct 28, 2016 12:00 pm UTC| Business
MALVERN, Pa., Oct. 28, 2016 -- Aclaris Therapeutics, Inc., (NASDAQ:ACRS), a dermatologist-led, specialty pharmaceutical company focused on the development of medical and aesthetic dermatology treatments, has been named...
Global Calcium Nitrate Market Expected to Reach USD 12.36 Billion by 2021: Zion Market Research
Oct 28, 2016 12:00 pm UTC| Business
Sarasota, FL, Oct. 28, 2016 -- Zion Research has published a new report titled “Calcium Nitrate Market by Application (Wastewater Treatment Chemicals, Fertilizers, Concrete Manufacturing, Explosives, and Others) -...
Oct 28, 2016 12:00 pm UTC| Business
BROOMFIELD, Colo, Oct. 28, 2016 -- Colorado Therapeutics LLC, a privately held medical device company with a proprietary technology platform for the production of innovative cross-linked tissue products, announced today...
Idera Pharmaceuticals Reports Third Quarter 2016 Financial Results
Oct 28, 2016 11:30 am UTC| Business
CAMBRIDGE, Mass. and EXTON, Pa., Oct. 28, 2016 -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel nucleic...
Genocea Presents New 12 month Data on Genital Herpes Immunotherapy GEN-003 at IDWeek 2016
Oct 28, 2016 11:30 am UTC| Business
- Increase in CD4+ polyfunctional T cells indicates GEN-003 is stimulating a multi-faceted T cell immune response to genital herpes - - GEN-003 elicited strong antibody responses at 12 months post-dosing - CAMBRIDGE,...